Host of bidders in race for AstraZeneca dental unit

Zimmer Holdings and Biomet are among the bidders for AstraZeneca's Astra Tech, a Swedish unit that makes dental implants and medical devices, sources told Bloomberg. Report

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.